BloodScan offers advanced circulating tumor cell (CTC) analysis services for academic researchers, biopharma, and cancer centers. By accessing our centralized labs, you can accelerate cancer research, drug development, and translational studies with biopsy-quality CTCs.

Track cell counts for prognostic insights and treatment monitoring.

Identify epithelial-to-mesenchymal transitions, linked to metastasis and drug resistance.

Detect CD44, ALDH1, and other markers for self-renewal and therapeutic resistance.

Quantify clusters associated with aggressive disease.

Transcriptome-level profiling for heterogeneity and drug targets.

Identify driver mutations and copy number changes in CTCs.

Detect rearrangements, fusions, or amplifications (e.g., ALK, ROS1, RET).

Correlate protein expression with disease stage, EMT, and therapy response.
We currently provide CTC analysis through two centralized laboratories:
Researchers can submit blood samples to either site, depending on location and preference. To learn more about our research services or request a customized quote, please contact us directly.